Wenchen Gong

956 total citations
39 papers, 400 citations indexed

About

Wenchen Gong is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wenchen Gong has authored 39 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Wenchen Gong's work include Lymphoma Diagnosis and Treatment (11 papers), RNA modifications and cancer (5 papers) and Viral-associated cancers and disorders (5 papers). Wenchen Gong is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), RNA modifications and cancer (5 papers) and Viral-associated cancers and disorders (5 papers). Wenchen Gong collaborates with scholars based in China, United States and Iran. Wenchen Gong's co-authors include Tieju Liu, Xueyi Dong, Xiulan Zhao, Danfang Zhang, Yuchao He, Bin Meng, Lihua Qiu, Xiubao Ren, Lanfang Li and Shiyong Zhou and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and British Journal of Cancer.

In The Last Decade

Wenchen Gong

34 papers receiving 399 citations

Peers

Countries citing papers authored by Wenchen Gong

Since Specialization

Citations

This map shows the geographic impact of Wenchen Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchen Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchen Gong more than expected).

Fields of papers citing papers by Wenchen Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenchen Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchen Gong. The network helps show where Wenchen Gong may publish in the future.

Co-authorship network of co-authors of Wenchen Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenchen Gong. A scholar is included among the top collaborators of Wenchen Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenchen Gong. Wenchen Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer 2025 ·Frontiers in Immunology ·(unknown), Xiangdong Tian, Fucheng Li, Xi Yu, Wenchen Gong, (unknown), Jianan Wang, Siqi Yang, Shaojun Zhang, Qian Zhang, Shanshan Yang	0
2	Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma 2025 ·Cell Death and Disease ·Yuchao He, Dongming Liu, (unknown), Zhiqiang Han, (unknown), Jinghui Cheng, (unknown), Wei Liu, Wenchen Gong, (unknown), Liwei Chen, Yi Luo, Yu Wang, Xiangdong Tian, Qiang Wu, Lu Chen, Hua Guo	3
3	Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy 2025 ·Cell Reports Medicine ·(unknown), Yuchao He, (unknown), (unknown), Xiangdong Tian, Duo Zuo, Yi Luo, Wei Liu, (unknown), (unknown), Ping Yue, Wenchen Gong, Yu Wang, Liwei Chen, Zhiyong Liu, Peng Chen, Hua Guo	1
4	5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma 2025 ·EMBO Molecular Medicine ·(unknown), (unknown), (unknown), Wenchen Gong, Yuan Gao, Yun Wang, Yu Wang, Wenshuai Chen, (unknown), (unknown), (unknown), (unknown), Hua Guo	1
5	Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses 2025 ·Leukemia ·Cong Sun, Wei Li, Jingwei Yu, (unknown), Wenchen Gong, Hengqi Liu, Fenghua Gao, (unknown), Lanfang Li, Lihua Qiu, (unknown), Shiyong Zhou, Bin Meng, Yanan Gao, (unknown), Xia Liu, Weicheng Ren, Qiang Pan‐Hammarström, Xianhuo Wang, (unknown)	1
6	CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma 2024 ·Cancer Gene Therapy ·(unknown), Yuchao He, (unknown), Wenchen Gong, Yu Wang, (unknown), (unknown), (unknown), Yuan Gao, Zhiyong Liu, (unknown), Hua Guo	2
7	Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma 2024 ·British Journal of Haematology ·Xuelei Li, Fenghua Gao, Xiangrui Meng, Xiaoyan Zhang, Cong Sun, (unknown), Jingwei Yu, Xia Liu, Xue Han, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, (unknown), Zahra Chavoshzadeh, Xiubao Ren, Xianhuo Wang, Huilai Zhang	2
8	OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma 2024 ·iScience ·Yali Wang, (unknown), Yuchao He, Wenchen Gong, Yanyan Cui, (unknown), Yu Wang, Yi Luo, Li-Wei Chen, Zhiyong Liu, Peng Chen, Hua Guo	2
9	PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway 2024 ·Cell Death and Disease ·(unknown), (unknown), Yuchao He, Wenchen Gong, Yu Wang, Li-Wei Chen, Yi Luo, Cuicui Zhang, Zhiyong Liu, (unknown), Hua Guo	18
10	OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma 2023 ·Clinical Immunology ·(unknown), Yang Li, (unknown), (unknown), Chengfeng Bi, (unknown), Lanfang Li, Lihua Qiu, (unknown), Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, Jamés O. Armitage, Huilai Zhang, Kai Fu, Xianhuo Wang	7
11	The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma 2023 ·Advanced Science ·Yuchao He, (unknown), (unknown), (unknown), (unknown), (unknown), Zhiyong Liu, Wenchen Gong, Liwei Chen, Yi Luo, Shaojun Zhang, Youwei Wang, Lu Chen, Hua Guo	20
12	The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma 2023 ·Frontiers in Genetics ·Liwei Chen, Yuchao He, Zhiqiang Han, Wenchen Gong, Xiangdong Tian, Lin Guo, Hua Guo, Tianqiang Song, Lu Chen	3
13	Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma 2023 ·International Journal of Biological Sciences ·(unknown), Yuchao He, (unknown), Wenchen Gong, (unknown), Yu Wang, Yi Luo, Liwei Chen, (unknown), (unknown), Hailing Lu, Zhiyong Liu, Peng Chen, (unknown)	20
14	A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma 2022 ·Clinical Immunology ·Xiaoxuan Wang, (unknown), (unknown), Wenchen Gong, (unknown), Tingting Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, (unknown), Shiyong Zhou, (unknown), Qiong-Li Zhai, Bin Meng, Xiubao Ren, Huilai Zhang, Xianhuo Wang	16
15	m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment 2022 ·Frontiers in Immunology ·Tingting Zhang, Hengqi Liu, Fenghua Gao, Wenchen Gong, Yao‐Li Cui, Jin He, Lanfang Li, Lihua Qiu, (unknown), Shiyong Zhou, Bin Meng, Xiubao Ren, Huilai Zhang, Xianhuo Wang	7
16	Molecular features and evolutionary trajectory of ASCL1+ and NEUROD1+ SCLC cells 2022 ·British Journal of Cancer ·Xuexi Zhang, Hao Wang, Wenxu Liu, (unknown), Zhenyi Ma, Zhenfa Zhang, Wenchen Gong, Jun Chen, Zhe Liu	11
17	An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy 2021 ·Frontiers in Oncology ·(unknown), Jingwei Yu, Wenchen Gong, Liping Su, Xiuhua Sun, Ou Bai, Hui Zhou, Xue Guan, Tingting Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Bin Meng, Xiubao Ren, Xianhuo Wang, Huilai Zhang	8
18	Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability 2021 ·Journal of Biological Chemistry ·Cheng Cao, (unknown), Ling Liu, Yiman Tang, Shanshan Tian, Kai Zhang, Lei Shi, Zhiqiang Liu, (unknown), Wenshu Ge, Wenchen Gong	6
19	Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma 2019 ·Cancer Biology and Medicine ·Lu Chen, (unknown), Wenchen Gong, Bo Sun, Guangtao Li, Dongming Liu, (unknown), Yuchao He, Ziye Chen, (unknown), (unknown), (unknown)	23
20	Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas 2019 ·Endocrine Pathology ·Jianghua Wu, Yanhui Zhang, Tingting Ding, Run-Fen Cheng, Wenchen Gong, Yuhong Guo, Ye Luo, Yi Pan, Qiong-Li Zhai, Wei Sun, Dongmei Lin, Baocun Sun	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact